“Framework” Provisions

  1. Law
  2. CFR 21
  3. Food and Drugs
  4. Food and Drug Administration, Department of Health and Human Services
  5. General
  6. Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and the European Community
  7. “Framework” Provisions

Checkout our iOS App for a better way to browser and research.

Section
26.60

Definitions.

Section
26.61

Purpose of this part.

Section
26.62

General obligations.

Section
26.63

General coverage of this part.

Section
26.64

Transitional arrangements.

Section
26.65

Designating authorities.

Section
26.66

Designation and listing procedures.

Section
26.67

Suspension of listed conformity assessment bodies.

Section
26.68

Withdrawal of listed conformity assessment bodies.

Section
26.69

Monitoring of conformity assessment bodies.

Section
26.70

Conformity assessment bodies.

Section
26.71

Exchange of information.

Section
26.72

Sectoral contact points.

Section
26.73

Joint Committee.

Section
26.74

Preservation of regulatory authority.

Section
26.75

Suspension of recognition obligations.

Section
26.76

Confidentiality.

Section
26.77

Fees.

Section
26.78

Agreements with other countries.

Section
26.79

Territorial application.

Section
26.80

Entry into force, amendment, and termination.

Section
26.81

Final provisions.